Alphagan Purite 1,5 mg/ml, Ophthalmic solution
PDF Leaflet Revision Date: 21 April 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Lowering intraocular pressure in open-angle glaucoma or ocular hypertension.
Dosage (summary)
One drop in affected eye(s) twice daily, 12 hours apart.
Onset of Action / Duration
Onset: 2 hours, Duration: Not specified.
Special Populations
- Paediatric use under 2 years
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety during pregnancy not established; avoid breastfeeding while using.
Key Drug Interactions
- Antihypertensives
- Digoxin
- CNS depressants
- Tricyclic antidepressants
- Monoamine oxidase inhibitors
Contraindications
- Hypersensitivity to brimonidine
- Neonates and infants under 2 years
Common side effects
- Allergic conjunctivitis
- Eye pruritus
- Dizziness
- Fatigue
- Hypertension
Counselling Points
- Avoid touching dropper tip to any surface
- Discard after 30 days of opening
- Monitor for drowsiness or blurred vision
Serious warnings
- Caution in severe cardiovascular disease
- Potential for contamination leading to infections
Important Disclaimer
The Alphagan Purite 1,5 mg/ml, Ophthalmic solution professional information leaflet below is the property of AbbVie and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
